Aarón Molina-Jaimes

ORCID: 0000-0002-9395-7068
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Bacterial Identification and Susceptibility Testing
  • Antibiotic Use and Resistance
  • Antibiotic Resistance in Bacteria
  • Long-Term Effects of COVID-19
  • Sarcoidosis and Beryllium Toxicity Research
  • Nosocomial Infections in ICU
  • Animal Virus Infections Studies
  • Infection Control in Healthcare
  • COVID-19 and Mental Health
  • Antibiotics Pharmacokinetics and Efficacy
  • Tumors and Oncological Cases
  • Marine Bivalve and Aquaculture Studies
  • Peripheral Neuropathies and Disorders
  • Viral-associated cancers and disorders
  • COVID-19 Impact on Reproduction
  • Infectious Diseases and Tuberculosis
  • Clostridium difficile and Clostridium perfringens research
  • Poxvirus research and outbreaks
  • Pancreatitis Pathology and Treatment
  • Histiocytic Disorders and Treatments

Institute for Social Security and Services for State Workers
2019-2023

Hospital Regional de Alta Especialidad del Bajío
2022

Instituto Nacional de Cancerología
2017

Aim: This study aims to assess the changes in antimicrobial resistance among some critical and high-priority microorganisms collected previously during coronavirus disease 2019 (COVID-19) pandemic Mexico. Methods: We susceptibility data for from blood, urine, respiratory samples, all specimens, which pathogen may be considered a causative agent. Data were stratified compared two periods: versus 2020 second semester (prepandemic) (pandemic). Results: In analysis of 2020, blood increased...

10.1089/mdr.2021.0231 article EN PubMed 2022-03-01

We aimed to assess the resistance rates of antimicrobial-resistant, in bacterial pathogens epidemiological importance 47 Mexican centers.In this retrospective study, we included a stratified sample centers, covering 20 states. Selected isolates considered as potential causatives disease collected over 6-month period were included. Laboratories employed their usual methods perform microbiological studies. The results deposited into database and analyzed with WHONET 5.6 software.In total...

10.1371/journal.pone.0209865 article EN cc-by PLoS ONE 2019-03-26

In this study, we report the carbapenemase-encoding genes and colistin resistance in Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa second year of COVID-19 pandemic. Clinical isolates included carbapenem-resistant K. E. A. P. aeruginosa. Carbapenemase-encoding were detected by PCR. Carbapenem-resistant pneumoniae coli analyzed using Rapid Polymyxin NP assay. mcr screened Pulsed-field gel electrophoresis whole-genome sequencing performed on...

10.1089/mdr.2022.0226 article EN Microbial Drug Resistance 2023-01-03

Rosai-Dorfman disease (RDD) a rare, non-malignant of histiocytic proliferation usually presents as painless lymphadenopathy. It has been associated with autoimmune diseases, viral infections, and malignancies. Management is the treatment underlying disease. Here we present case patient HIV infection who presented massive splenomegaly

10.1016/j.idcr.2020.e00698 article EN cc-by-nc-nd IDCases 2020-01-01

Introduction: Severe acute respiratory syndrome-related coronavirus (SARS-CoV-2) infection is characterised by a viral phase and severe pro-inflammatory phase. The inhibition of the JAK/STAT pathway limits state in moderate to COVID-19.
 Methodology: We analysed data obtained an observational cohort patients with SARS-CoV-2 pneumonia treated ruxolitinib 22 hospitals Mexico. applied dose was determined based on physician’s criteria. benefit evaluated using 8-points ordinal scale...

10.3855/jidc.15126 article EN cc-by The Journal of Infection in Developing Countries 2022-01-31

The orthopoxvirus, which also includes the smallpox virus, is what causes monkeypox. Several endemics have been found in Africa, mostly western and central parts of continent. But since May 13, 2022, several cases reported from different member states. number proven one month was higher than total recorded outside Africa first case 1970. World Health Organization (WHO) Centers for Disease Control Prevention (CDC) think that monkeypox a very important disease health people around world....

10.36346/sarjms.2023.v05i04.005 article EN South Asian Research Journal of Medical Sciences 2023-08-26

Cutaneous tuberculosis is dangerous. The M. complex causes 1.5–3% of extrapulmonary cases. This chronic illness needs long care. Tuberculous primary complex, commonly known as inoculated tuberculosis, a rare (1%) clinical and histological diagnosis. To provide histopathological case skin with an unusual presentation immunization mechanism, to emphasize the significance early detection minimize sequelae infections. A 52-year-old man has rheumatoid arthritis systemic hypertension. It started...

10.36346/sarjams.2023.v05i06.002 article EN South Asian Research Journal of Applied Medical Sciences 2023-11-02

Background. The COVID-19 disease is characterized by its severe form in which pneumonia and cytokine hypersecretion are observed. Currently, one of the main lines treatment has been aimed at controlling hyperinflammatory state host. Material Methods. An open-label, multicenter, non-randomized, phase II clinical trial was conducted patients with moderate to SARS-CoV-2 treated ruxolitinib 5 mg twice daily for 14 days along standard care. use dexamethasone allowed under investigator’s...

10.34141/ljcs7467753 article EN Latin American Journal of Clinical Sciences and Medical Technology 2023-10-18

Abstract Background HH is a key component to decrease infections in hospitals, but compliance HCW remains low. We present six-month strategy empower patients’ caregivers on compliance. Methods HCWs was evaluated between June 1 and August 31, 2017 as recommended by WHO. Between September 1, 2016 March we undertook the empowering hematology-oncology ward (50 beds) from Instituto Nacional de Cancerologia, cancer referral, teaching hospital Mexico. To patients their caregivers, member of team...

10.1093/ofid/ofx163.1032 article EN cc-by-nc-nd Open Forum Infectious Diseases 2017-01-01

Abstract Background Clostridioides difficile (C. difficile) infection is the main cause of nosocomial diarrhea in world. In our hospital, there was no standardized protocol for diagnosis and treatment this infection. The aim study to measure impact implementing a multimodal strategy active surveillance, clinical outcome patients with C. Methods Observational, retrospective, analytical that compared against traditional strategy, which consisted either metronidazole or vancomycin variable...

10.1093/ofid/ofz360.2064 article EN cc-by-nc-nd Open Forum Infectious Diseases 2019-10-01

Melioidosis is a disease of low incidence in Latin America caused by the Gram-negative bacillus Burkholderia pseudomallei.This endemic Southeast Asia and Northeastern Australia.The main risk factor diabetes mellitus.Pulmonary followed intra-abdominal manifestations most common form clinical presentation, where liver affected organ.We present case Mexican male who had hepatic melioidosis secondary to skin dissemination.The microbiological diagnosis was made according recommended standards...

10.24875/hmcm.20000186 article EN Hospital medicine and clinical management 2020-03-26

Introduction: Severe acute respiratory syndrome-related coronavirus (SARS-CoV-2) infection is characterised by a viral phase and severe pro-inflammatory phase. The inhibition of the JAK/STAT pathway limits state in moderate to COVID-19 cases. Methods: We analysed data obtained for an observational cohort patients with SARS-CoV-2 pneumonia treated ruxolitinib 22 hospitals Mexico. dose used was determined based on physician’s criteria. benefit evaluated using 8-points ordinal scale developed...

10.22541/au.164864609.91408352/v1 preprint EN Authorea (Authorea) 2022-03-30

Abstract Background The surge of resistant Gram-negative organisms has been worrying infectious disease physicians and in general because the lack a large number antibiotics to which these remain susceptible. Ceftazidime-Avibactam (CAZ-AVI) is drug approved by FDA treat complicated urinary tract infections (cUTI), intra-abdominal (cIAIs) combination with metronidazole, recently for treatment nosocomial pneumonia. Worldwide resistance rates Enterobacteriaceae CAZ-AVI have reported below 2.6%,...

10.1093/ofid/ofab466.1482 article EN cc-by Open Forum Infectious Diseases 2021-11-01

Abstract Background Mexico is one of the top five countries with a higher mortality rate hospitalized patients 30.1%. Since COVID-19 has been associated immune dysregulation and hyper inflammation, JAK-12 inhibitors have tested to reduce IL6 production. Studies shown improvements when using ruxolitinib (rxb) in severely COVID-19. These included combination corticosteroids such as dexamethasone (dxm). This work aims test response severe or critical treated rxb without dxm. Methods An...

10.1093/ofid/ofab466.754 article EN cc-by Open Forum Infectious Diseases 2021-11-01
Coming Soon ...